Marques Tiago

Chief Executive Officer

DirectorOfficer

Latest Insider Transactions

3 transactions (past 365 days)

KTTA
CEO
Purchase
$25K
33,333 shares @ $0.75
Filed 2025-12-01Trade 2025-11-28
Pasithea Therapeutics Corp.
KTTA
CEO
Award
$0
493,341 shares @ $0.00
Filed 2025-10-27Trade 2025-10-24
Pasithea Therapeutics Corp.
KTTA
CEO
Sale
-$792
960 shares @ $0.83
Filed 2025-05-14Trade 2025-05-12
Pasithea Therapeutics Corp.

Marques Tiago is a corporate insider with SEC Form 4 filings on record. No transactions have been reported in the past 12 months. Historical filings, if any, are searchable below.